Dr. Siamak Afshar

D.D.S. | Dentist



  
  11623 Cherry Ave, Suite B-2, Fontana
  California, 92337-1212

  909-355-1485    Maps & Directions
Dr. Siamak Afshar is a Fontana, California based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 11623 Cherry Ave, Suite B-2, Fontana. Patients can reach him at 909-355-1485.
Dr. Siamak Afshar is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Siamak Afshar speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Siamak Afshar
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:11623 Cherry Ave, Suite B-2, Fontana,
California, 92337-1212
Phone:909-355-1485
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 2961707427
Enrollment ID: I20160219002040
NPI Number: 1689718108
NPI Enumeration Date: 16 Feb, 2007
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 5712 Larry Dean St,
Corona, California
Zip: 92880-3150
Phone Number: 909-923-9724
Patients can reach Dr. Siamak Afshar at 11623 Cherry Ave, Suite B-2, Fontana, California or can call to book an appointment on 909-355-1485. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: